The Chairman of the Presidential Committee on Fiscal Policy and Tax Reforms, Taiwo Oyedele has assured Nigerians that the new tax laws will lighten the burden for most citizens, contrary to widespread ...

Penny Gusner is a senior insurance writer and analyst at Forbes Advisor. For more than 20 years, she has been helping consumers learn how insurance laws, data, trends, and coverages affect them. Penny ...

Shipping companies A.P. Moller-Maersk (OTCPK:AMKBY) (OTCPK:AMKAF) and Hapag-Lloyd (OTCPK:HPGLY) (OTCPK:HLAGF) -6.6% and -7.5%, respectively, in Friday's trading as container freight rates on major ...

Your heart rate, also known as your pulse, is a standard measurement of how many times your heart beats per minute. It increases or decreases depending on how hard you’re exerting yourself. As such, ...

Estimate how much your money can grow with our free investment return calculator. Enter your planned contributions, timeline, rate of return and compounding frequency to get started. Many, or all, of ...

The reduction in GST rates is forecast to drive a 200 basis points (bps) upshift in two-wheeler demand and a 100 bps increase for PVs Two-wheeler sales volume is expected to grow by 5-6 per cent in ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

[Stay on top of transportation news: Get TTNews in your inbox.] The freight market showed signs of recovery in the second quarter despite ongoing issues preventing it from truly turning a corner, ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Historical Data is currently not available. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Dr Maurie Markman discusses a recent study focused on immunotherapy in the inpatient setting for patients with stage IV cancer.